Australia Últimas notícias

Pending sales of previously owned US homes dropped in July to the weakest since the start of the year. Bloomberg Intelligence's Drew Reading has more.

Home Depot Inc.'s results beat estimates in the latest quarter, a sign that spending on improvement projects is holding up despite high borrowing and housing costs. Bloomberg's Lindsay Dutch joins to discuss.

Anthropic PBC is on track to generate annualized revenue of more than $65 billion based on its current performance, according to people familiar with the matter, up more than sevenfold from its pace at the end of last year. Bloomberg's Mandeep Singh joins Bloomberg Intelligence to discuss.

A selloff in chipmakers sent stocks lower, with the market also falling as inflation angst and rising government debt kept bond yields elevated. Longer-dated bonds are at the epicenter of anxiety about everything from inflation to the debt-laden artificial-intelligence boom. Liz Ann Sonders, Chief Investment Strategist at Charles Schwab, discusses the gap between sell-side consensus and buy-side expectations.

A selloff in chipmakers sent stocks lower, with the market also falling as inflation angst and rising government debt kept bond yields elevated. John Mowrey, CIO at NFJ Investment Group, discusses AI capex spending and equities reaching all-time highs.

Bank of Israel Governor Amir Yaron says Israel's economy has shown resilience during the war in Iran but warns there's a big fiscal policy challenge ahead. He speaks with Dani Burger on "Bloomberg Open Interest."

On this episode of Stock Movers: - Shares of Klarna (KLAR) plunged in premarket trading after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. The company cited foreign exchange pressures and volumes in Germany, even as it reported a profit beat for the second straight quarter. - Shares of Amylyx Pharmaceuticals (AMLX) extended its rally in the early session to as much as 54%, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience low blood sugar levels following bariatric surgery. - Shares of Bath & Body Works (BBWI) surged ahead of the opening bell after Citi raised its recommendation on the stock to buy from neutral. Analyst Paul Lejuez cited a favorable risk/reward outlook in his note. The company is slated to release earnings next week.

The RealReal CEO Rati Levesque joins Bloomberg Open Interest to explain why resale prices are increasingly shaping what shoppers buy new, with more than 80% of Gen Z and millennial customers checking secondhand values first. She also reveals which unexpected fashion pieces are appreciating, and why AI still can't fully replace human luxury authenticators.

Private credit is returning to the bond market in a big way. Blackstone's BCRED raised $750 million and Blue Owl sold $400 million as strong demand helped drive record August investment-grade issuance. Bloomberg's Kat Hidalgo explains why investors are coming back,  but still favor safer exposure higher in the capital stack.

Goldman Sachs struck its second deal in a week as the firm pushes ahead with plans to grow its $4 trillion money-management arm. The company will pay as much as $410 million to buy LCN Capital Partners, a commercial real estate investor that focuses on sale-leaseback agreements and triple-net leases. Todd Gillespie has more on "Bloomberg Open Interest."

JP Morgan's Gabriela Santos says AI remains the biggest theme in global markets but investors may be dangerously concentrated. She explains why recurring AI selloffs are inevitable, where investors can still find diversification, and how massive tech borrowing is quietly extending AI risk from stocks into bonds.

JPMorgan's Gabriela Santos says investors don't have to abandon the AI boom to protect themselves from the next selloff. She explains why AI-driven volatility is likely to keep returning, and identifies Treasuries, gold, core real estate and European stocks as potential portfolio shock absorbers.